New Intact Mass software application on waters_connect enables simplified and significantly faster analysis of biomolecules for mass and purity
This recognition earns Waters designation as one of the Best Places to Work for LGBTQ+ Equality
Waters Corporation has announced the appointment of Wei Jiang to its Board of Directors, effective July 14, 2021. Mr. Jiang currently serves as Executive Vice President and President,...
Waters Corporation has introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method...
Currently serves on the boards of Cygnal Therapeutics and KSQ Therapeutics.
Michael Silveira Appointed Interim CFO, Effective January 1, 2021
Dr. Batra succeeds Christopher O’Connell
Waters enables core product portfolio with next-generation automation technology.